Ozempic goes from threat to opportunity for packaged-food makers
Less than a year ago, the head of Novo Nordisk A/S was fielding calls from “scared” food industry executives about his company’s blockbuster drug that suppressed cravings.
Tomas Kauer 
Less than a year ago, the head of Novo Nordisk A/S was fielding calls from “scared” food industry executives about his company’s blockbuster drug that suppressed cravings. Read More
